CommercialCoverageMedium impact
Redirection of Care Update - addition of Saphnelo
Blue Cross Blue Shield of Wyoming·WY · Rheumatology, Internal Medicine, Nephrology·Pharmacy
Effective date
May 1, 2025
We identified it
Jun 19, 2026
Summary
Blue Cross Blue Shield of Wyoming is adding Saphnelo (HCPCS J0491) to their Redirection of Care program effective May 1, 2025. This lupus medication will require special site-of-care considerations for infusion, though medical necessity criteria remain unchanged.
Action Required
By May 1, 2025: Billing team must verify Saphnelo (J0491) claims follow BCBSWY Redirection of Care program requirements for site-of-care infusion drugs. Review updated Medical Policy 12.01.002 and FEP Medical Policy 5.99.023. Contact Provider Relations at 1-888-666-5188 for questions about billing location requirements.